Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
The Column Group
company
About
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
- 11 - 50
Highlights
Details
- Industries
- Biotechnology,Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
Investments
Number of Investments
Number of Lead Investments
18
5
The Column Group has made 18 investments. Their most recent investment was on
Nov 29, 2022, when Cajal Neuroscience raised $96M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2022
Cajal Neuroscience
|
Series A | $96M | Biotechnology | Yes |
|
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
|
May 5, 2021
Eikon Therapeutics
|
Series A | $148M | Biotechnology | Yes |
|
Mar 1, 2021
Tenaya Therapeutics
|
Series C | $106M | Biopharma | — |
|
Oct 6, 2020
A2 Biotherapeutics
|
Series B | $71.50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
